| J9271 | Injection, pembrolizumab, 1 mg | 8,400 | $40 | $361.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 480 | $90 | $43.7K |
| J0897 | Injection, denosumab, 1 mg | 1,800 | $20 | $32.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 190 | $100 | $19K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 200 | $90 | $18.6K |
| Q5122 | Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | 180 | $100 | $17.1K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 90 | $160 | $14.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 210 | $70 | $13.3K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 5,620 | $1 | $11.2K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 310 | $20 | $5.6K |